clofibrate has been researched along with Acute Kidney Injury in 10 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To examine the role of stimulated FAO during ischemia, Etomoxir (Eto), clofibrate, and WY-14,643 compounds were given 5 days prior to the induction of ischemia/reperfusion (I/R) injury." | 3.70 | Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure. ( Crew, MD; Dai, G; Gonzalez, FJ; Peters, JM; Portilla, D; Proia, AD, 2000) |
| " The recommended dosage of clofibrate is 1." | 1.26 | [Fat and renal failure--therapeutic aspects]. ( Heidland, A; Hörl, M; Hörl, WH, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YT | 1 |
| Jenq, CC | 1 |
| Hsu, CK | 1 |
| Yu, YC | 1 |
| Chang, CH | 1 |
| Fan, PC | 1 |
| Pan, HC | 1 |
| Wu, IW | 1 |
| Cherng, WJ | 1 |
| Chen, YC | 1 |
| Patschan, D | 1 |
| Schwarze, K | 1 |
| Henze, E | 1 |
| Patschan, S | 1 |
| Scheidemann, R | 1 |
| Müller, GA | 1 |
| Newaz, M | 1 |
| Yousefipour, Z | 1 |
| Oyekan, A | 1 |
| Meffin, PJ | 1 |
| Zilm, DM | 1 |
| Veenendaal, JR | 1 |
| Hörl, WH | 1 |
| Hörl, M | 1 |
| Heidland, A | 1 |
| Heidemann, H | 1 |
| Bock, KD | 1 |
| Cumming, A | 1 |
| Portilla, D | 1 |
| Dai, G | 1 |
| Peters, JM | 1 |
| Gonzalez, FJ | 1 |
| Crew, MD | 1 |
| Proia, AD | 1 |
| Dosa, S | 1 |
| Mallick, NP | 1 |
| Slotki, IN | 1 |
| Cuculanu, MP | 1 |
| Vasile, VV | 1 |
| Popescu, TA | 1 |
| Opincaru, A | 1 |
| Crîsnic, I | 1 |
| Tapalagå, D | 1 |
10 other studies available for clofibrate and Acute Kidney Injury
| Article | Year |
|---|---|
Acute kidney disease and acute kidney injury biomarkers in coronary care unit patients.
Topics: Acute Disease; Acute Kidney Injury; Age Factors; Aged; Biomarkers; Body Weight; Clofibrate; Coronary | 2020 |
Fibrate treatment of eEOCs in murine AKI.
Topics: Acute Kidney Injury; Animals; Apoptosis; Cell Movement; Cell Survival; Cells, Cultured; Clofibrate; | 2014 |
Role of PPAR-gamma on the pathogenesis and vascular changes in glycerol-induced acute renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Kidney Injury; Angiotensin | 2006 |
Reduced clofibric acid clearance in renal dysfunction is due to a futile cycle.
Topics: Acute Kidney Injury; Animals; Carbon Radioisotopes; Clofibrate; Clofibric Acid; Creatinine; Glucuron | 1983 |
[Fat and renal failure--therapeutic aspects].
Topics: Acute Kidney Injury; Animals; Bezafibrate; Carnitine; Charcoal; Clofibrate; Clofibric Acid; Humans; | 1982 |
[Rhabdomyolysis with acute renal failure due to bezafibrate].
Topics: Acute Kidney Injury; Bezafibrate; Clofibrate; Clofibric Acid; Humans; Male; Middle Aged; Muscular Di | 1981 |
Acute renal failure and interstitial nephritis after clofibrate treatment.
Topics: Acute Kidney Injury; Clofibrate; Humans; Male; Middle Aged; Nephritis, Interstitial | 1980 |
Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Carnitine O-Palmitoyltransferase; Clofibrate; Cre | 2000 |
Letter: Acute-on-chronic renal failure precipitated by clofibrate.
Topics: Acute Kidney Injury; Adult; Clofibrate; Female; Humans; Hyperlipidemias; Kidney Failure, Chronic; Ma | 1976 |
Clinical studies concerning factor XIII; with special reference to hyperlipemia.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Arteriosclerosis; Blood Cell Count; Blood Coagulation | 1973 |